UroViu Launches Uro-GHD, a New High-Definition Sterile Single-Use Cystoscope
The Uro-GHD features a 1280×720 pixel sensor, a first in portable, single-use endoscopy.
Uro-GHD
LOS ALTOS, Calif….
Premium Healthcare First in the Nation to Debut AI Powered Heart Valve Disease Detection Program
Premium Healthcare Beacon Campus is the first medical institute in the nation to deploy SENSORA™ Cardiac Disease Platform by Eko Health to identify structural heart disease
Premium Healthcare SENSORA\u2122 Screening
Valerie Rodriguez MSN, APRN, FNP-BC co-founder of Premium Healthcare’s Cardiac Department conducting a SENSORA\u2122 Screening on a female patient.
MIAMI, April 6, 2023 (Newswire.com)
–
Premium Healthcare has announced the implementation of SENSORA™ Cardiac Disease Detection Platform by Eko Health to identify structural heart disease. With the launch of Eko Health technology, Premium Healthcare is advancing the way to more accurately and consistently identify valvular heart disease (VHD) in patients during routine visits with their primary care physician (PCP).
“I was brought in to use this advanced new equipment. In what felt like a few moments I was done and received my results immediately. It was a painless quick procedure. Thank god everything is great, and I don’t have anything to worry about,” said Oscar Peñaber, a 72-year-old patient at Premium Healthcare Plus Senior Medical Center.
By combining murmur analysis artificial intelligence (AI) with its digital stethoscopes, Eko Health has pioneered a non-invasive detection platform that can identify structural murmurs in seconds, so patients can get the treatment they need sooner. Premium Healthcare is the first healthcare institution in the United States to deploy SENSORA™ for structural murmur detection, which was recently cleared by the U.S. Food and Drug Administration (FDA).
VHD, the most common type of structural heart disease, is a life-threatening condition diagnosed in more than 8 million Americans. Left undetected and untreated, it can lead to heart failure, stroke, blood clots, and death. Older adults have approximately a 1 in 10 chance of developing clinically significant VHD. However, more than half (57%) of clinically significant valvular heart disease goes undetected in this population. SENSORA™ for structural murmur detection more than doubles the likelihood of detecting significant VHD.
“The primary care setting is a patient’s first line of defense for identifying and diagnosing heart disease. However, we know from clinical evidence that detection rates are low,” said Dr. Keila Hoover M.D, Founder and CEO of Premium Healthcare. “We’re excited about the promise of this technology to better serve our patient community by increasing the accuracy and consistency of structural murmur identification and improving the quality of referrals for valve disease treatment.”
Premium Healthcare will debut the use of SENSORA™ for structural murmur detection at their newly opened 5-story tower building, Beacon Campus, on 69th Ave SW Coral Way and their Senior Medical Center in the heart of Westchester, FL.
Premium Healthcare is South Florida’s fastest-growing medical centers, and their introduction of Eko Health’s SENSORA™ Platform at the Beacon Campus is evidence of the medical organization’s commitment to fast-paced technological advancements.
For more information about SENSORA™ at Premium Healthcare call 786-523-3836 or visit premiumhealthcare.com.
Contact Information:
Daniel Gonzalez
Marketing Manager
(786)523-3836
Carlos De Cespedes
Co Owner of Premium Healthcare Plus Senior Medical Center
(305)586-1234
Original Source:
Premium Healthcare First in the Nation to Debut AI Powered Heart Valve Disease Detection Program
The Intelligent Health Data Symposium Goes Hybrid
TIFF Bell Lightbox will be the site for health IT adventurers this spring at Smile Digital Health's first-ever in-person IHD.
TORONTO, April 6, …
Virgo and CTNx Partner to Power GI Clinical Trials
Network of high-quality research sites will leverage endoscopy AI platform to expand and accelerate enrollment in gastroenterology clinical trials.
…
Korbel California Champagne Returns for Third Season as Official Bubbly of the Boston Red Sox
Brands Continue Tradition of Being Part of Some of America’s Most Celebrated Moments
Korbel Champagne The Official Bubbly of The Boston Red Sox
Stadium, BRS logo, Korbel Brut bottle
GUERNEVILLE, Calif., April 6, 2023 (Newswire.com)
–
The 123rd season of Boston Red Sox baseball has begun, with Korbel® California Champagne returning once again as the “Official Bubbly” for the third consecutive season. Since 1901, the team has won nine World Series championships and tied for the third-most of any Major League baseball team — cementing its iconic legacy as a cornerstone of American baseball. The partnership is a unique collaboration as both brands possess a rich and long-standing tradition in some of America’s most celebrated moments in sports and everyday occasions.
Whether sipping mimosas while watching a day game or popping a bottle for the biggest of wins, Korbel has a sparkler for every occasion. Toasting the ordinary, extraordinary, and everything in between for 141 years and counting, the longevity, values, and quality that comprise both brands are a natural fit. We lift our glasses to the continued partnership of these two American classics.
Established in 1882 in Sonoma County’s Russian River Valley, Korbel® California Champagne produces the United States’ most popular méthode champenoise champagne. The true measure of Korbel’s success during its 141 years can be seen in the impact it has had on American consumers and its presence at various celebrations throughout the years. Owned and managed by the Heck family since 1954, Korbel currently makes 11 California champagnes and a limited amount of still wine. In a separate facility, Korbel also produces one of the country’s most respected brandies.
Celebrate responsibly.
F. Korbel & Bros., Guerneville, Sonoma County, California.
Producers of fine California méthode champenoise champagnes for 141 years.
KORBEL is a registered trademark. ©2023 F. Korbel & Bros. All rights reserved.
To find out more about responsible consumption, visit Responsibility.org and OurThinkingAboutDrinking.com.
All other trademarks and trade names are properties of their respective owners.
Contact Information:
Margie Healy
Vice President of Communications
4156064567
Related Files
2023 Korbel Red Sox Release FINAL DRAFT.docx
Original Source:
Korbel California Champagne Returns for Third Season as Official Bubbly of the Boston Red Sox
The post Korbel California Champagne Returns for Third Season as Official Bubbly of the Boston Red Sox first appeared on RSVTV news.
Auditory Processing Institute Study Finds Long COVID ‘Brain Fog’ Linked to Auditory Processing Disorder, an Underdiagnosed Neurological Disorder
First Study of Its Kind Outlines Symptoms and Uncovers Proactive Steps Patients Can Take to Get Treatment
Auditory Processing Institute logo for Auditory Processing Institute
…
NuEyes to Launch Their Next Generation Smart Glasses Aimed at the Medical and Dental Market
NuLoupes will bring surgical and dental loupes into the 21st century with its revolutionary technology and ecosystem for medical professionals
NuLo…
NuEyes to Launch Their Next Generation Smart Glasses Aimed at the Medical and Dental Market
NuLoupes will bring surgical and dental loupes into the 21st century with its revolutionary technology and ecosystem for medical professionals
NuLo…
NuEyes to Launch Their Next Generation Smart Glasses Aimed at the Medical and Dental Market
NuLoupes will bring surgical and dental loupes into the 21st century with its revolutionary technology and ecosystem for medical professionals
NuLo…
America’s #1 Regenerative Medicine and Orthopedic Surgery Practice in Dallas, Texas, Leads NIH-Funded Clinical Research Study on Sustained Acoustic Medicine for Knee OA
Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Insti…